Description

Description

Linjardy MXR 12.5/2.5/1000mg is a once-daily, extended-release triple combination tablet built for patients who need a stronger SGLT2 component alongside the same background Linagliptin and Metformin doses, packaged 14 tablets to a pack. It combines Empagliflozin, an SGLT2 inhibitor that helps the kidneys clear excess glucose through urine, Linagliptin, a DPP-4 inhibitor that supports insulin release around mealtimes while reducing the liver’s glucose output, and an extended-release form of Metformin, which steadily improves the body’s sensitivity to its own insulin throughout the day. This strength is typically chosen when a patient’s blood sugar isn’t adequately controlled on the lower Empagliflozin dose within this triple combination, allowing a stronger SGLT2 effect while keeping the other two components unchanged.

Ingredients

Each Linjardy MXR 12.5/2.5/1000mg tablet contains:

• Empagliflozin – 12.5 mg (immediate-release layer)
• Linagliptin – 2.5 mg
• Metformin Hydrochloride – 1000 mg (extended-release core)

The tablet also contains standard inactive excipients that form the extended-release matrix and outer film coating, which regulate the gradual release of Metformin and support easy swallowing, without any therapeutic effect of their own.

Dosage Form

Linjardy MXR 12.5/2.5/1000mg is manufactured as an extended-release, film-coated oral tablet, supplied 14 tablets per pack, intended for once-daily oral use.

Uses

Linjardy MXR 12.5/2.5/1000mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus who need a stronger SGLT2 inhibitor dose within a triple-mechanism combination
• Allow patients already stabilized on Empagliflozin 12.5mg, Linagliptin, and Metformin taken as separate medicines to move to a more convenient once-daily extended-release tablet
• Support long-term diabetes management, including potential cardiovascular and kidney-related benefits, when paired with an appropriate diet and consistent physical activity

It is not intended for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The points below are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take the tablet once daily, generally with the evening meal, as directed by your doctor.
• Swallow the tablet whole with a glass of water; because it is extended-release, never crush, split, or chew it, as this can cause the metformin dose to release too quickly.
• It’s normal to occasionally notice the outer tablet shell in the stool, since this part of the extended-release matrix is not fully absorbed; this does not mean the medicine was ineffective.
• Maintain a consistent daily timing to help support stable blood sugar management.
• Attend recommended blood tests, including kidney function monitoring, since safe use at this higher Empagliflozin strength depends closely on adequate kidney health.

Side Effects

Side effects can vary between individuals, but commonly reported ones with this combination include:

• Nausea, diarrhea, or general stomach discomfort, typically milder than with immediate-release metformin, especially once the body adjusts
• Increased urinary frequency, often more noticeable at this higher Empagliflozin dose
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections
• Upper respiratory symptoms such as a runny or stuffy nose

Less commonly, more serious concerns can occur, including lactic acidosis (a rare but serious risk associated with metformin, more likely with reduced kidney or liver function), signs of pancreatitis such as persistent abdominal pain, joint pain associated with DPP-4 inhibitors, or symptoms suggesting diabetic ketoacidosis such as ongoing nausea, vomiting, or abdominal pain even when blood glucose readings appear normal. Any of these symptoms warrant urgent medical attention. This overview is not exhaustive, so any unusual or persistent symptom should be discussed with a doctor or pharmacist.

Pregnancy & Breastfeeding

Linjardy MXR 12.5/2.5/1000mg is generally not recommended during pregnancy, since the Empagliflozin component may affect fetal kidney development, particularly in later stages of pregnancy, and diabetes management in pregnant women is typically handled through alternative approved treatments under specialist care. It is also generally not advised while breastfeeding. Women who are pregnant, planning to become pregnant, or currently breastfeeding should speak with their doctor before starting or continuing this medication.

Storage Instructions

• Store Linjardy MXR 12.5/2.5/1000mg tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and excess humidity.
• Keep tablets in their original blister packaging until they are needed.
• Store out of reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

How does the 12.5/2.5/1000mg strength differ from the 5/2.5/1000mg version?
Both contain the same Linagliptin and Metformin doses, but this version has a higher Empagliflozin strength, generally chosen when stronger SGLT2 inhibition is needed for adequate blood sugar control.

Why can’t I crush or split this tablet?
Doing so would disrupt the extended-release mechanism, causing the full metformin dose to release at once instead of gradually, which raises the risk of digestive side effects.

Will I notice more urination at this higher Empagliflozin dose?
Some patients experience a more noticeable increase in urinary frequency at this strength, which is generally expected and manageable with adequate fluid intake.

Can I switch directly to this strength from a lower Linjardy MXR dose?
No, dose changes should always be made gradually and only under a doctor’s supervision, based on your blood sugar response and overall tolerance.

Is more frequent monitoring needed at this strength?
Yes, your doctor may recommend closer monitoring of kidney function and hydration status, particularly when starting or adjusting to this dose.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.